|
|
|
40
|
55511
|
THALIDOMIDE 50MG CAP (DIL/AHI)
|
THALIDOMIDE
|
THALIDOMIDE
|
30'S
|
C
|
62.25
|
2.08
|
CAPSULE
|
0
|
CAP
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
55511
|
THALIDOMIDE 50MG CAP (DIL)
|
THALIDOMIDE
|
THALIDOMIDE
|
30'S
|
C
|
48.11
|
1.60
|
CAP
|
0
|
BLIS
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
BIOLOGIC RESPONSE MODIFIER
|
|
|
|
|
40
|
55521
|
THALIDOMIDE 100MG CAP (DIL/AHI)
|
THALIDOMIDE
|
THALIDOMIDE
|
30'S
|
C
|
110.50
|
3.68
|
CAPSULE
|
0
|
CAP
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
55521
|
THALIX 100MG CAP (DIL) THALIDOMIDE
|
THALIDOMIDE
|
THALIX
|
30'S
|
C
|
60.18
|
2.01
|
CAP
|
0
|
BLIS
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
BIOLOGIC RESPONSE MODIFIER
|
|
|
|
|
40
|
5552D
|
THALIDOMIDE 100MG CAP (SLS/AHI)
|
THALIDOMIDE
|
THALIDOMIDE
|
30'S
|
C
|
93.78
|
3.13
|
CAPSULE
|
0
|
CAP
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat C
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2021-12-16
|
|
|
|
41
|
5552D
|
THALIDOMIDE 100MG CAP (SLS)
|
THALIDOMIDE
|
THALIDOMIDE
|
30'S
|
C
|
63.5
|
2.1167
|
CAP
|
0
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
BIOLOGIC RESPONSE MODIFIER
|
|
|
|
|
40
|
55618
|
CANESTEN-3 200MG VAG. P (BSP/AHI) CLOTRIMAZOL
|
CLOTRIMAZOLE
|
CANESTEN-3
|
3'S
|
C
|
9.27
|
10.19
|
VAGINAL PESS
|
1
|
PACK
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081408
|
AZOLES
|
2022-04-01
|
2024-03-31
|
|
VAGINAL
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-29
|
|
|
|
40
|
55618
|
CANESTEN-3 200MG VAG PESS (BSP/AHI) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN-3
|
3'S
|
A
|
10.19
|
10.19
|
VAGINAL PESS
|
|
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
81408
|
AZOLES
|
2023-02-21
|
2024-03-31
|
Add to Contract as Cat A
|
VAGINAL
|
0
|
AZOLES
|
2023-02-21
|
|
|
|
41
|
55618
|
CANESTEN-3 200MG VAG PESS (BSP) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN-3
|
3'S
|
A
|
9.19
|
9.1879
|
PACK
|
1
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081408
|
AZOLES
|
2024-04-01
|
2026-03-31
|
|
VAGINAL
|
0
|
AZOLES
|
|
|
|
|
42
|
55618
|
CANESTEN-3 200MG VAG OV (BSP) CLOT (C)
|
CLOTRIMAZOLE
|
CANESTEN-3
|
3'S
|
C
|
9.19
|
9.19
|
PACK
|
1
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081408
|
AZOLES
|
2026-04-01
|
2028-03-31
|
|
VAGINAL
|
0
|
AZOLES
|
2026-02-11
|
|
|
|
40
|
5561AA
|
CANESTEN-3 200MG VAG OV (BSP/COL) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN-3
|
3'S
|
A
|
9.87
|
9.87
|
VAGINAL OVUL
|
1
|
PACK
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081408
|
AZOLES
|
2022-04-01
|
2024-03-31
|
|
VAGINAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5561AA
|
CANESTEN-3 200MG VAG OV (BSP) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN-3
|
3'S
|
A
|
9.19
|
9.1879
|
PACK
|
1
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081408
|
AZOLES
|
2024-04-01
|
2026-03-31
|
|
VAGINAL
|
0
|
AZOLES
|
|
|
|
|
42
|
5561AA
|
CANESTEN-3 200MG VAG OV (BSP) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN-3
|
3'S
|
C
|
7.23
|
7.23
|
PACK
|
1
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
081408
|
AZOLES
|
2026-04-01
|
2028-03-31
|
|
VAGINAL
|
0
|
AZOLES
|
|
|
|
|
40
|
5561AB
|
CANESTEN 500MG VAG OV (BSP/COL) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN
|
1'S
|
A
|
11.88
|
11.88
|
VAGINAL OVUL
|
1
|
PACK
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081408
|
AZOLES
|
2022-04-01
|
2024-03-31
|
|
VAGINAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5561AB
|
CANESTEN 500MG VAG OV (BSP) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN
|
1'S
|
A
|
11.04
|
11.0364
|
PACK
|
1
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081408
|
AZOLES
|
2024-04-01
|
2026-03-31
|
|
VAGINAL
|
0
|
AZOLES
|
|
|
|
|
42
|
5561AB
|
CANESTEN 500MG VAG OV (BSP) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN-1
|
1'S
|
C
|
10.03
|
10.03
|
PACK
|
1
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
081408
|
AZOLES
|
2026-04-01
|
2028-03-31
|
|
VAGINAL
|
0
|
AZOLES
|
|
|
|
|
40
|
5561AC
|
CANESTEN-6 1% VAG CR (BSP/COL) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN-6
|
35G
|
A
|
9.41
|
9.41
|
VAGINAL CREA
|
1
|
TUBE
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081408
|
AZOLES
|
2022-04-01
|
2024-03-31
|
|
VAGINAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5561AC
|
CANESTEN-6 1% VAG CR (BSP) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN-6
|
35G
|
A
|
8.73
|
8.7258
|
TUBE
|
1
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081408
|
AZOLES
|
2024-04-01
|
2026-03-31
|
|
VAGINAL
|
0
|
AZOLES
|
|
|
|
|
42
|
5561AC
|
CANESTEN-6 1% VAG CR (BSP) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN-6
|
35G
|
A
|
11.15
|
11.15
|
TUBE
|
1
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
081408
|
AZOLES
|
2026-04-01
|
2028-03-31
|
|
VAGINAL
|
0
|
AZOLES
|
|
|
|
|
40
|
5561AD
|
CANESTEN-3 2% VAG CR (BSP/COL) CLOTRIMAZOLE
|
CLOTRIMAZOLE
|
CANESTEN-3
|
20G
|
C
|
10.36
|
10.36
|
VAGINAL CREA
|
0
|
TUBE
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081408
|
AZOLES
|
2022-04-01
|
2024-03-31
|
|
VAGINAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
